Twitter

Archive for October 18th, 2011


Halozyme Announces Positive Results from Roche’s Subcutaneous Herceptin Phase 3 Trial

… CD20+ non-Hodgkin’s lymphoma (NHL) and Chronic Lymphocytic Leukaemia (CLL). About the HannaH trial HannaH is … with non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Pending the successful achievement of a …

Read More...

Leukemia patient uses social media to find bone marrow match

… fatigue, breathlessness and sudden weight loss. On Sept. 22, he was diagnosed with acute leukemia. He has about six weeks to find a bone marrow match, which could save …

Read More...

A Royal Charity Step-Up: Kate Middleton Writes Letter to Leukemia Patient

… keep him in her prayers. The duchess met Fabian Bate, who is suffering from leukemia, on Sept. 29, when she, along with Prince William, opened the new Oak Centre …

Read More...

Kate writes moving letter to boy fighting leukaemia

… Cambridge, Kate Middleton wrote a moving letter to a nine-year-old boy who is battling leukaemia. Kate, 29, wrote the heartfelt note to the boy after her visit to the …

Read More...

Kate Middleton pens moving letter of support to nine-year-old cancer patient

… visit to the Royal Marsden hospital. Catherine sent the note of support to young leukaemia sufferer Fabian Bate, with whom she spent time when she and William attended the …

Read More...

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Conditions :   Urologic Neoplasms;   Metastatic Bladder Cancer;   Urinary Tract Neoplasms Interventions :   Drug: OGX-427 600 mg;   Drug: OGX-427 1000 mg;   Drug: Placebo Sponsors :   OncoGenex Technologies;   OncoGenex Pharmaceuticals;   PRA International Not yet recruiting – verified October 2011

Read More...

Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets

Condition :   Advanced Pancreatic Carcinoma Interventions :   Drug: gemcitabine, or gemcitabine and capecitabine, or gemcitabine and erlotinib, or FOLFIRINOX, or FOLFOX, or FOLFIRI.;   Drug: Gemcitabine, Gemcitabine-Capecitabine, Gemcitabine-Erlotinib, FOLFOXIRI, FOLFOX, FOLFIRI Sponsors :   Centro Nacional de Investigaciones Oncologicas CARLOS III;   Hospital Universitario Fuenlabrada;   Apices Soluciones S.L.;   Grupo Hospital de Madrid Recruiting – verified October 2011

Read More...

Long-term Consequences of Bereavement in Children, Adolescents and Young Adults

Condition :   Bereavement Intervention :   Sponsors :   Danish Cancer Society;   Department of Epidemiology Research, Statens Serum Institute;   Department of Patient Support & Community, Danish Cancer Society;   Center for Crisis Psychology, Norway;   Danish Counselling and Research Center for Grieving Children, Teens and Young Ad;   Children’s Welfare Recruiting – verified October 2011

Read More...

Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma

Condition :   Hodgkin Lymphoma Interventions :   Drug: DHAP;   Drug: Everolimus Sponsor :   University of Cologne Not yet recruiting – verified October 2011

Read More...

Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma

Conditions :   Lymphoma;   Waldenstrom’s Macroglobulinemia;   Nonhematologic Malignancies Interventions :   Drug: MLN9708 Capsule B formulation;   Drug: MLN9708 Capsule A or B formulation;   Drug: MLN9708 Capsule B formulation Sponsor :   Millennium Pharmaceuticals, Inc. Not yet recruiting – verified October 2011

Read More...